Related Experiment Video
Updated: Aug 5, 2026

Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis
Published on: August 9, 2013
[Study on the inhibitory effect of antisense phosphorothioate oligodeoxynucleotide on coxsackie virus B replication
Objective:
To investigate the antiviral effect of antisense phosphorothioate oligodeoxynucleotide (AODN) on CVB3 replication in vitro.
Methods:
In this study, 21 mer antisense phosphorothioate oligodeoxynucleotide which complemented to nt 581-601 in 5' NCR of Coxsackie Virus B3 (CVB3) RNA was used to investigate antiviral activity in Vero cells as a specific inhibitor of CVB3 replication. Specific AODN of CVB3 RNA, sense oligodeoxynucleotide (SODN) and randomized nonsense-sequence RODN were synthesized for effect comparison among them. Vero cells infected by CVB3 were transfected with different concentrations of AODN mediated by lipofectamine reagent, so that the cells could take in more AODN. Cell control and viral control were set up. The inhibitory effect of AODN on CVB3 replication was evaluated with a number of variables, including inhibitory rates of cytopathic effect (CPE), cell survival rates by MTT assay, inhibitory rates of CVB3 antigen by ELISA, inhibitory rates of RNA by dot blotting and 50% tissue culture infective dose (TCID50).
Results:
The specific AODN could significantly inhibit CPE of CVB3-infected Vero cells, decrease the production of antigen and RNA of CVB3 and viral titers, and increase cell survival rates, in a dose-dependent manner. The strongest inhibitory effect appeared at 48 hours after transfection, the most effective concentration of AODN was 10 micromol/L. On the other hand, 10 micromol/L SODN also showed weaker inhibitory effect on CPE of CVB3-infected cells, but no antiviral effect of 10 micromol/L RODN was shown. AODN showed no-inhibition on HSV-1 replication, but inhibited some enteroviruses such as CVB3, Polio-1 and Echo-6 to some extent.
Conclusions:
These results indicate that nt 581-601 in 5' NCR of CVB3 RNA may play an important role in regulating CVB3 replication and AODN may have inhibitory effect on CVB3 replication.
Insights
Antisense phosphorothioate oligodeoxynucleotide (AODN) effectively inhibited Coxsackie Virus B3 (CVB3) replication in vitro. This specific AODN demonstrated dose-dependent antiviral activity against CVB3, highlighting its potential as a therapeutic agent.
Area of Science:
- Virology
- Molecular Biology
- Antiviral Therapy
Background:
- Coxsackie Virus B3 (CVB3) is a significant human pathogen.
- Effective antiviral strategies against CVB3 are crucial for public health.
- Antisense oligodeoxynucleotides (AODN) show promise as targeted antiviral agents.
Purpose of the Study:
- To evaluate the in vitro antiviral efficacy of a specific antisense phosphorothioate oligodeoxynucleotide (AODN).
- To investigate the inhibitory effect of AODN on CVB3 replication in Vero cells.
- To compare the antiviral activity of AODN with sense (SODN) and randomized (RODN) oligodeoxynucleotides.
Main Methods:
- Synthesis of a 21-mer AODN targeting the 5' NCR of CVB3 RNA (nt 581-601).
- Transfection of CVB3-infected Vero cells with varying concentrations of AODN, SODN, and RODN using lipofectamine.
- Assessment of antiviral effects through inhibition of cytopathic effect (CPE), cell viability (MTT assay), viral antigen and RNA levels (ELISA, dot blotting), and viral titers (TCID50).
Main Results:
- AODN significantly inhibited CVB3-induced CPE, viral antigen and RNA production, and viral titers in a dose-dependent manner.
- Optimal inhibition was observed at 48 hours post-transfection with 10 µmol/L AODN, which also enhanced cell survival rates.
- SODN exhibited a weaker inhibitory effect on CPE, while RODN showed no antiviral activity; AODN did not inhibit HSV-1 but showed some effect against other enteroviruses like Polio-1 and Echo-6.
Conclusions:
- The 5' NCR region (nt 581-601) of CVB3 RNA is critical for viral replication.
- AODN targeting this region demonstrates significant potential for inhibiting CVB3 replication.
- AODN represents a promising strategy for developing targeted antiviral therapies against CVB3 and potentially other enteroviruses.
Related Concept Videos
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly

